Serina Therapeutics, Inc.
General ticker "SER" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $48.9M (TTM average)
Serina Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -16.9%.
Estimated limits based on current volatility of 3.4%: low 2.72$, high 2.92$
Factors to consider:
- Total employees count: 12 as of 2018
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.52$, 7.95$]
- 2025-12-31 to 2026-12-31 estimated range: [1.93$, 6.07$]
Short-term SER quotes
Long-term SER plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.50MM | $3.15MM | $0.06MM |
| Operating Expenses | $2.77MM | $6.28MM | $17.10MM |
| Operating Income | $-2.27MM | $-3.13MM | $-17.05MM |
| Non-Operating Income | $-0.41MM | $8.40MM | $5.84MM |
| Interest Expense | $0.02MM | $0.56MM | $0.53MM |
| R&D Expense | $1.57MM | $2.39MM | $7.48MM |
| Income(Loss) | $-2.68MM | $5.27MM | $-11.21MM |
| Profit(Loss)* | $-2.68MM | $5.27MM | $-11.14MM |
| Stockholders Equity | $-17.21MM | $-32.29MM | $0.64MM |
| Assets | $3.24MM | $8.97MM | $6.72MM |
| Operating Cash Flow | $-2.08MM | $-2.48MM | $-17.14MM |
| Capital expenditure | $0.01MM | $0.50MM | $0.02MM |
| Investing Cash Flow | $0.98MM | $-0.50MM | $-0.02MM |
| Financing Cash Flow | $1.31MM | $10.07MM | $13.21MM |
| Earnings Per Share** | $-2.49 | $0.63 | $-1.51 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.